Financhill
Sell
43

ACCS Quote, Financials, Valuation and Earnings

Last price:
$11.66
Seasonality move :
3.87%
Day range:
$11.30 - $12.19
52-week range:
$7.61 - $13.35
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.06x
P/B ratio:
1.44x
Volume:
16.8K
Avg. volume:
7.7K
1-year change:
39.11%
Market cap:
$44.5M
Revenue:
$23.1M
EPS (TTM):
-$1.38

Earnings Data

Next earnings date for ACCS
Aug 08
2025
Most recent earnings per share
$1.40
Beat by $1.40
(May 13/2025)
Consensus Estimate
--
(May 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ACCS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/08/2025 Q2 $5.8M -- -- $0.09 --
05/13/2025 Q1 -- $5.5M $1.40 -- --
03/25/2025 Q4 $7.4M $1.5M -$2.66 $0.23 -$2.89
11/07/2024 Q3 $7.1M $7M -$0.12 $0.20 -$0.32
06/30/2024 Q2 $7.6M $7.7M $0.00 $0.21 -$0.21
03/31/2024 Q1 $8.6M $5.6M -$0.04 $0.29 -$0.33
12/31/2023 Q4 $8.2M -$1.3M -$0.19 $0.26 -$0.45
09/30/2023 Q3 $8.9M $7.6M $0.07 $0.35 -$0.28
06/30/2023 Q2 $10.4M $9.7M $0.36 $0.42 -$0.06
03/31/2023 Q1 $8.6M $8.6M -$0.04 $0.31 -$0.35
12/31/2022 Q4 -- $7.1M -$0.03 -- --
09/30/2022 Q3 -- $5.3M $0.19 -- --
06/30/2022 Q2 -- $5.8M $0.22 -- --
03/31/2022 Q1 -- $5.3M $0.13 -- --
12/31/2021 Q4 -- $5.7M $0.16 -- --
09/30/2021 Q3 -- $5.5M $0.27 -- --
06/30/2021 Q2 -- $5.7M $0.29 -- --
03/31/2021 Q1 -- $5M $0.14 -- --
12/31/2020 Q4 -- $4.7M $0.08 -- --
09/30/2020 Q3 -- $4.9M $0.21 -- --
06/30/2020 Q2 -- $4.9M $0.21 -- --
03/31/2020 Q1 -- $4M $0.06 -- --
12/31/2019 Q4 -- $4M $0.02 -- --
09/30/2019 Q3 -- $4M $0.05 -- --
06/30/2019 Q2 -- $4.1M $0.05 -- --
03/31/2019 Q1 -- $4.2M $0.05 -- --
12/31/2018 Q4 -- $3.6M $0.02 -- --
09/30/2018 Q3 -- $3.3M $0.02 -- --
06/30/2018 Q2 -- $3.8M $0.12 -- --
03/31/2018 Q1 -- $3.5M $0.10 -- --
12/31/2017 Q4 -- $3.4M $0.24 -- --
09/30/2017 Q3 -- $2.9M $0.10 -- --
06/30/2017 Q2 -- $3.4M $0.16 -- --
03/31/2017 Q1 -- $2.9M $0.11 -- --
12/31/2016 Q4 -- $2.8M $0.17 -- --
09/30/2016 Q3 -- $2.9M $0.07 -- --
06/30/2016 Q2 -- $3.1M $0.12 -- --
03/31/2016 Q1 -- $3.3M $0.17 -- --
12/31/2015 Q4 -- $2.7M -$0.11 -- --
09/30/2015 Q3 -- $2.8M $0.05 -- --
06/30/2015 Q2 -- $3.1M $0.03 -- --

ACCESS Newswire Earnings Questions

  • How Much did ACCESS Newswire Generate in Revenue Last Quarter?

    ACCESS Newswire reported $5.5M worth of top line sales in its most recent quarter.

  • Did ACCESS Newswire Beat Earnings Last Quarter?

    ACCESS Newswire announced earnings per share of $1.40 which represents a beat of analyst forecast a -- per share.

  • Is ACCESS Newswire Profitable?

    ACCESS Newswire reported $4.3M that represents $1.11 per share over the last quarter.

  • What is the Analyst Consensus for ACCESS Newswire EPS Next Year?

    ACCESS Newswire's earnings are forecast to grow from -$2.82 per share to $0.71 per share next year representing an increase of 255%.

  • When is ACCESS Newswire's Earnings Date?

    ACCESS Newswire's next earnings date is August 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Kestra Medical Stock Be in 1 Year?
Where Will Kestra Medical Stock Be in 1 Year?

Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…

Why Did Howard Marks Buy Grab Stock?
Why Did Howard Marks Buy Grab Stock?

When a legendary value investor who cut his teeth in…

Why Did Warren Buffett Buy Amazon Stock?
Why Did Warren Buffett Buy Amazon Stock?

When investors think of tech stocks in Warren Buffett’s portfolio,…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
88
CDTX alert for Jun 24

Cidara Therapeutics [CDTX] is up 3.18% over the past day.

Sell
46
HIMS alert for Jun 24

Hims & Hers Health [HIMS] is up 2.26% over the past day.

Buy
67
WGS alert for Jun 24

GeneDx Holdings [WGS] is up 13.99% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock